As shown in Figure 8, two commonly used chemotherapy drugs in breast cancer therapy, cisplatin and docetaxel were associated with higher sensitivities in the low MKL1 expression group than in the high expression group (p = 7.21 × 10−3 for cisplatin and p = 4.37 × 10−5 for docetaxel). Here, MRTFA is linked to breast cancer.